Antigen presentation and T cell stimulation by dendritic cells
P Guermonprez, J Valladeau, L Zitvogel… - Annual review of …, 2002 - annualreviews.org
Dendritic cells take up antigens in peripheral tissues, process them into proteolytic peptides,
and load these peptides onto major histocompatibility complex (MHC) class I and II …
and load these peptides onto major histocompatibility complex (MHC) class I and II …
Review Article The immunology and immunotherapy of breast cancer: an update
JW Hadden - International journal of immunopharmacology, 1999 - Elsevier
Adenocarcinomas of the breast behave clinically and epidemiologically in ways that show
host resistance factors are important for outcome in addition to grade and stage of …
host resistance factors are important for outcome in addition to grade and stage of …
The dendritic cell and human cancer vaccines
RM Dallal, MT Lotze - Current opinion in immunology, 2000 - Elsevier
Over the past ten years, the identification of the critical role that dendritic cells (DCs) play in
stimulating a specific immune response has led to their use in cancer and HIV therapy …
stimulating a specific immune response has led to their use in cancer and HIV therapy …
Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination
M Schott, J Seissler, M Lettmann… - The Journal of …, 2001 - academic.oup.com
Recent studies suggest that immunization with autologeous dendritic cells (DCs) pulsed with
tumor antigen result in protective immunity and rejection of established tumors in various …
tumor antigen result in protective immunity and rejection of established tumors in various …
Pancreatic ductal adenocarcinoma: a review of immunologic aspects
MB Wachsmann, LM Pop… - Journal of Investigative …, 2012 - journals.sagepub.com
With the continued failures of both early diagnosis and treatment options for pancreatic
cancer, it is now time to comprehensively evaluate the role of the immune system on the …
cancer, it is now time to comprehensively evaluate the role of the immune system on the …
A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late‐stage lung …
GC Chang, HC Lan, SH Juang, YC Wu, HC Lee… - Cancer, 2005 - Wiley Online Library
BACKGROUND The authors conducted a pilot clinical trial to explore the vaccination of
patients with late‐stage lung carcinoma with dendritic cells (DCs) pulsed with necrotic tumor …
patients with late‐stage lung carcinoma with dendritic cells (DCs) pulsed with necrotic tumor …
The role of CD8+ T cells in immune responses to colorectal cancer
LV Titu, JR Monson, J Greenman - Cancer Immunology, Immunotherapy, 2002 - Springer
Cytotoxic T lymphocytes (CTL) are essential effectors of the cell-mediated immune
response. The ability of CTL to specifically recognise and lyse malignant cells expressing …
response. The ability of CTL to specifically recognise and lyse malignant cells expressing …
Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A* 0201 and HLA-A* 2402 late-stage colorectal cancer patients after vaccination with …
KJ Liu, CC Wang, LT Chen, AL Cheng, DT Lin… - Clinical cancer …, 2004 - AACR
Purpose: We intranodally immunized metastatic colorectal carcinoma patients, who had
failed standard chemotherapy, with dendritic cells (DCs) pulsed with HLA-A* 0201-or HLA …
failed standard chemotherapy, with dendritic cells (DCs) pulsed with HLA-A* 0201-or HLA …
Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2‐derived peptide‐pulsed dendritic cell vaccines
S Yamaguchi, T Tatsumi, T Takehara… - … Journal of the …, 2007 - Wiley Online Library
BACKGROUND. Further optimization of dendritic cell (DC)‐based vaccines is required
clinically against advanced stage cancer. Given the broad range of expression levels …
clinically against advanced stage cancer. Given the broad range of expression levels …
Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing
JA Weidanz, T Nguyen, T Woodburn… - The Journal of …, 2006 - journals.aai.org
Recognition of tumor-associated Ags (TAAs) on tumor cells by CTLs and the subsequent
tumor cell death are assumed to be dependent on TAA protein expression and to correlate …
tumor cell death are assumed to be dependent on TAA protein expression and to correlate …